NCT07232537: An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea

Sponsor: Bayer. Phase: . Conditions: Chronic Kidney Disease, Type 2 Diabetes Mellitus